RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Charles T. Spencer to Lymphocyte Activation

This is a "connection" page, showing publications Charles T. Spencer has written about Lymphocyte Activation.
Connection Strength

0.482
  1. Spencer CT, Abate G, Blazevic A, Hoft DF. Only a subset of phosphoantigen-responsive gamma9delta2 T cells mediate protective tuberculosis immunity. J Immunol. 2008 Oct 01; 181(7):4471-84.
    View in: PubMed
    Score: 0.301
  2. Xia M, Hesser DC, De P, Sakala IG, Spencer CT, Kirkwood JS, Abate G, Chatterjee D, Dobos KM, Hoft DF. A Subset of Protective ?9d2 T Cells Is Activated by Novel Mycobacterial Glycolipid Components. Infect Immun. 2016 09; 84(9):2449-62.
    View in: PubMed
    Score: 0.130
  3. Abate G, Spencer CT, Hamzabegovic F, Blazevic A, Xia M, Hoft DF. Mycobacterium-Specific ?9d2 T Cells Mediate Both Pathogen-Inhibitory and CD40 Ligand-Dependent Antigen Presentation Effects Important for Tuberculosis Immunity. Infect Immun. 2016 02; 84(2):580-9.
    View in: PubMed
    Score: 0.031
  4. Lee K, Gudapati P, Dragovic S, Spencer C, Joyce S, Killeen N, Magnuson MA, Boothby M. Mammalian target of rapamycin protein complex 2 regulates differentiation of Th1 and Th2 cell subsets via distinct signaling pathways. Immunity. 2010 Jun 25; 32(6):743-53.
    View in: PubMed
    Score: 0.021
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support